- Home
- SLGL vs FTEL Comparison
SLGL vs FTEL Comparison
Compare SLGL & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- FTEL
- Stock Information
- Founded
- SLGL 1997
- FTEL 2007
- Country
- SLGL Israel
- FTEL Australia
- Employees
- SLGL N/A
- FTEL N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- SLGL Health Care
- FTEL
- Exchange
- SLGL Nasdaq
- FTEL Nasdaq
- Market Cap
- SLGL 19.3M
- FTEL 19.3M
- IPO Year
- SLGL 2018
- FTEL 2023
- Fundamental
- Price
- SLGL $11.00
- FTEL $0.92
- Analyst Decision
- SLGL Buy
- FTEL
- Analyst Count
- SLGL 1
- FTEL 0
- Target Price
- SLGL $40.00
- FTEL N/A
- AVG Volume (30 Days)
- SLGL 10.1K
- FTEL 530.9K
- Earning Date
- SLGL 08-15-2025
- FTEL 08-05-2025
- Dividend Yield
- SLGL N/A
- FTEL N/A
- EPS Growth
- SLGL N/A
- FTEL N/A
- EPS
- SLGL N/A
- FTEL N/A
- Revenue
- SLGL $12,103,000.00
- FTEL $4,990,695.00
- Revenue This Year
- SLGL N/A
- FTEL N/A
- Revenue Next Year
- SLGL $31.17
- FTEL N/A
- P/E Ratio
- SLGL N/A
- FTEL N/A
- Revenue Growth
- SLGL 603.66
- FTEL 29.02
- 52 Week Low
- SLGL $3.34
- FTEL $0.36
- 52 Week High
- SLGL $16.50
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- SLGL 80.53
- FTEL 74.99
- Support Level
- SLGL $9.17
- FTEL $0.66
- Resistance Level
- SLGL $8.49
- FTEL $1.20
- Average True Range (ATR)
- SLGL 0.68
- FTEL 0.11
- MACD
- SLGL 0.33
- FTEL 0.02
- Stochastic Oscillator
- SLGL 97.35
- FTEL 58.24
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.